The GALT rush: High carrier frequency of an unusual deletion mutation of the GALT gene in the Ashkenazi population

Classic galactosemia is an autosomal recessive disorder of galactose metabolism manifesting in the first weeks of life following exposure to a milk-based diet. Despite the benefit of avoidance of lactose, many patients suffer from long-term complications including neurological deficits and ovarian f...

Full description

Saved in:
Bibliographic Details
Published inMolecular genetics and metabolism Vol. 102; no. 2; pp. 157 - 160
Main Authors Goldstein, Nurit, Cohen, Yoram, Pode-Shakked, Ben, Sigalov, Ekaterina, Vilensky, Bela, Peleg, Leah, Anikster, Yair
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Classic galactosemia is an autosomal recessive disorder of galactose metabolism manifesting in the first weeks of life following exposure to a milk-based diet. Despite the benefit of avoidance of lactose, many patients suffer from long-term complications including neurological deficits and ovarian failure. To date, over 230 mutations have been described in the GALT gene resulting in galactosemia. Recently, an unusual mutation was characterized causing a 5.5 kb deletion, with a relatively high carrier rate in subjects of Ashkenazi Jewish (AJ) descent. The aim of this study was to estimate the carrier frequency of this mutation in the AJ population in Israel. For this purpose we developed a high-throughput methodology to genotype both normal and deleted alleles using a chip-based matrix-assisted laser desorption-time-of-flight (MALDI-TOF) mass spectrometer and Multiplex PCR. DNA samples of 760 anonymous AJ subjects were submitted for analysis, subsequently detecting six individuals heterozygous for the GALT deletion mutation, giving a carrier frequency of 1 in 127 (0.79%). Based on these results, we suggest that the method described here provides a basis for genetic screening and prenatal counseling and can potentially reduce the morbidity and mortality associated with delayed diagnosis of galactosemia in this patient population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1096-7192
1096-7206
1096-7206
DOI:10.1016/j.ymgme.2010.10.007